Higher exosomal tau, amyloid-beta 42 and IL-10 are associated with mild TBIs and chronic symptoms in military personnel

References

• Yurgil KA, Barkauskas DA, Vasterling JJ, Nievergelt CM, Larson GE, Schork NJ, Litz BT, Nash WP, Baker DG, Marine Resiliency Study T. Association between traumatic brain injury and risk of posttraumatic stress disorder in active-duty marines. JAMA Psychiatry. 2014; 71(2): 149–57. doi: 10.1001/jamapsychiatry.2013.3080.
   PubMed Web of Science ®Google Scholar
• Mac Donald CL, Johnson AM, Wierzechowski L, Kassner E, Stewart T, Nelson EC, Werner NJ, Adam OR, Rivet DJ, Flaherty CS, et al. Outcome trends after US military concussive traumatic brain injury. J Neurotrauma. 2016; 4: 12–18.
   PubMed Web of Science ®Google Scholar
• Mac Donald CL, Johnson AM, Wierzechowski L, Kassner E, Stewart T, Nelson EC, Werner NJ, Adam OR, Rivet DJ, Flaherty SF, et al. Outcome trends after US military concussive traumatic brain injury. J Neurotrauma. 2016; 22: 23–31.
   PubMed Web of Science ®Google Scholar
• Adam O, Mac Donald CL, Rivet D, Ritter J, May T, Barefield M, Duckworth J, LaBarge D, Asher D, Drinkwine B, et al. Clinical and imaging assessment of acute combat mild traumatic brain injury in Afghanistan. Neurology. 2015; 85(3): 219–27. doi: 10.1212/WNL.0000000000001758.
   PubMed Web of Science ®Google Scholar
• Olivera A, Lejbman N, Jeromin A, French LM, Kim HS, Cashion A, Mysliwiec V, Diaz-Arrastia R, Gill J. Peripheral total tau in military personnel who sustain traumatic brain injuries during deployment. JAMA Neurol. 2015; 72(10): 1109–16. doi: 10.1001/jamaneurol.2015.1383.
   PubMed Web of Science ®Google Scholar
• Lejbman N, Olivera A, Heinzelmann M, Feng R, Yun S, Kim HS, Gill J. Active duty service members who sustain a traumatic brain injury have chronically elevated peripheral concentrations of Abeta40 and lower ratios of Abeta42/40. Brain Inj. 2016; 30(12): 1436–41. doi: 10.1080/02699052.2016.1219054.
   PubMed Web of Science ®Google Scholar
• Bogoslovsky T, Wilson D, Chen Y, Hanlon D, Gill J, Jeromin A, Song L, Moore C, Gong Y, Kenney K, et al.. Increases of plasma levels of glial fibrillary acidic protein, tau, and amyloid beta up to 90 days after traumatic brain injury. J Neurotrauma. 2016; 5: 70–79.
   PubMed Web of Science ®Google Scholar
• McKee AC, Cairns NJ, Dickson DW, Folkerth RD, Keene CD, Litvan I, Perl DP, Stein TD, Vonsattel JP, Stewart W, et al. The first NINDS/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta Neuropathol. 2016; 131(1): 75–86. doi: 10.1007/s00401-015-1515-z.
   PubMed Web of Science ®Google Scholar
• Stein TD, Montenigro PH, Alvarez VE, Xia W, Crary JF, Tripodis Y, Daneshvar DH, Mez J, Solomon T, Meng G, et al. Beta-amyloid deposition in chronic traumatic encephalopathy. Acta Neuropathol. 2015; 130(1): 21–34. doi: 10.1007/s00401-015-1435-y.
   PubMed Web of Science ®Google Scholar
• Barrio JR, Small GW, Wong K-P, Huang S-C, Liu J, Merrill DA, Giza CG, Fitzsimmons RP, Omalu B, Bailes J, et al. In vivo characterization of chronic traumatic encephalopathy using [F-18]FDDNP PET brain imaging. Proc Natl Acad Sci U S A. 2015; 112(16): E2039–47. doi: 10.1073/pnas.1409952112.
   PubMed Web of Science ®Google Scholar
• Gatson JW, Stebbins C, Mathews D, Harris TS, Madden C, Batjer H, Diaz-Arrastia R, Minei JP. Evidence of increased brain amyloid in severe TBI survivors at 1, 12, and 24 months after injury: report of 2 cases. J Neurosurg. 2016; 124(6): 1646–53. doi: 10.3171/2015.6.JNS15639.
   PubMed Web of Science ®Google Scholar
• McKee CA, Lukens JR. Emerging roles for the immune system in traumatic brain injury. Front Immunol. 2016; 7: 556. doi: 10.3389/fimmu.2016.00556.
   PubMed Web of Science ®Google Scholar
• Plesnila N. The immune system in traumatic brain injury. Curr Opin Pharmacol. 2016; 26: 110–17. doi: 10.1016/j.coph.2015.10.008.
   PubMed Web of Science ®Google Scholar
• Tang D, Kang R, Coyne CB, Zeh HJ, Lotze MT. PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol Rev. 2012; 249(1): 158–75. doi: 10.1111/imr.2012.249.issue-1.
   PubMed Web of Science ®Google Scholar
• Ferreira LC, Regner A, Miotto KD, Moura S, Ikuta N, Vargas AE, Chies JA, Simon D. Increased levels of interleukin-6, -8 and -10 are associated with fatal outcome following severe traumatic brain injury. Brain Inj. 2014; 28(10): 1311–16. doi: 10.3109/02699052.2014.916818.
   PubMed Web of Science ®Google Scholar
• Schneider Soares FM, Menezes de Souza N, Liborio Schwarzbold M, Paim Diaz A, Costa Nunes J, Hohl A, Nunes Abreu da Silva P, Vieira J, Lisboa de Souza R, More Bertotti M, et al. Interleukin-10 is an independent biomarker of severe traumatic brain injury prognosis. Neuroimmunomodulation. 2012; 19(6): 377–85.
   PubMed Web of Science ®Google Scholar
• Woiciechowsky C, Schoning B, Cobanov J, Lanksch WR, Volk HD, Docke WD. Early IL-6 plasma concentrations correlate with severity of brain injury and pneumonia in brain-injured patients. J Trauma. 2002; 52(2): 339–45.
   PubMedGoogle Scholar
• Bersani FS, Wolkowitz OM, Lindqvist D, Yehuda R, Flory J, Bierer LM, Makotine I, Abu-Amara D, Coy M, Reus VI, et al. Global arginine bioavailability, a marker of nitric oxide synthetic capacity, is decreased in PTSD and correlated with symptom severity and markers of inflammation. Brain Behav Immun. 2016; 52: 153–60. doi: 10.1016/j.bbi.2015.10.015.
   PubMed Web of Science ®Google Scholar
• Devoto C, Arcurio L, Fetta J, Ley M, Rodney T, Kanefsky R, Gill J. Inflammation relates to chronic behavioral and neurological symptoms in military with traumatic brain injuries. Cell Transplantation. 2016; doi: 10.3727/096368916X693455.
   Web of Science ®Google Scholar
• Hoge E, Brandstetter K, Moshier S, Pollack M, Wong K, Simon N. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress Anxiety. 2009; 26(5): 447–55. doi: 10.1002/da.v26:5.
   PubMed Web of Science ®Google Scholar
• Tucker P, Jeon-Slaughter H, Pfefferbaum B, Khan Q, Davis N. Emotional and biological stress measures in Katrina survivors relocated to Oklahoma. Am J Disaster Med. 2009; 5(2): 113–25. doi: 10.5055/ajdm.2010.0013.
   Google Scholar
• Lindqvist D, Wolkowitz OM, Mellon S, Yehuda R, Flory JD, Henn-Haase C, Bierer LM, Abu-Amara D, Coy M, Neylan TC. Proinflammatory milieu in combat-related PTSD is independent of depression and early life stress. Brain Behav Immun. 2014; 42: 81–88. doi: 10.1016/j.bbi.2014.06.003.
   PubMed Web of Science ®Google Scholar
• Zhou J, Nagarkatti P, Zhong Y, Ginsberg JP, Singh NP, Zhang J, Nagarkatti M. Dysregulation in microRNA expression is associated with alterations in immune functions in combat veterans with post-traumatic stress disorder. PLoS One. 2014; 9(4): e94075. doi: 10.1371/journal.pone.0094075.
   PubMed Web of Science ®Google Scholar
• Taylor DD, Gercel-Taylor C. Exosome platform for diagnosis and monitoring of traumatic brain injury. Philos Trans R Soc Lond B Biol Sci. 2014; 369: 1652. doi: 10.1098/rstb.2013.0503.
   Web of Science ®Google Scholar
• Korkut C, Ataman B, Ramachandran P, Ashley J, Barria R, Gherbesi N, Budnik V. Trans-synaptic transmission of vesicular Wnt signals through Evi/Wntless. Cell. 2009; 139(2): 393–404. doi: 10.1016/j.cell.2009.07.051.
   PubMed Web of Science ®Google Scholar
• Fruhbeis C, Frohlich D, Kuo WP, Amphornrat J, Thilemann S, Saab AS, Kirchhoff F, Mobius W, Goebbels S, Nave KA, et al. Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte–neuron communication. PLoS Biol. 2013; 11(7): e1001604. doi: 10.1371/journal.pbio.1001604.
   PubMed Web of Science ®Google Scholar
• Mittelbrunn M, Sanchez-Madrid F. Intercellular communication: diverse structures for exchange of genetic information. Nat Rev Mol Cell Biol. 2012; 13(5): 328–35. doi: 10.1038/nrm3335.
   PubMed Web of Science ®Google Scholar
• Stern RA, Tripodis Y, Baugh CM, Fritts NG, Martin BM, Chaisson C, Cantu RC, Joyce JA, Shah S, Ikezu T, et al. Preliminary study of plasma exosomal tau as a potential biomarker for chronic traumatic encephalopathy. J Alzheimers Dis. 2016; 51(4): 1099–109. doi: 10.3233/JAD-151028.
   PubMed Web of Science ®Google Scholar
• Rajendran L, Honsho M, Zahn TR, Keller P, Geiger KD, Verkade P, Simons K. Alzheimer’s disease beta-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci U S A. 2006; 103(30): 11172–77. doi: 10.1073/pnas.0603838103.
   PubMed Web of Science ®Google Scholar
• Kapogiannis D, Boxer A, Schwartz JB, Abner EL, Biragyn A, Masharani U, Frassetto L, Petersen RC, Miller BL, Goetzl EJ. Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer’s disease. FASEB J. 2015; 29(2): 589–96. doi: 10.1096/fj.14-262048.
   PubMed Web of Science ®Google Scholar
• Goetzl EJ, Boxer A, Schwartz JB, Abner EL, Petersen RC, Miller BL, Kapogiannis D. Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease. Neurology. 2015; 85(1): 40–47. doi: 10.1212/WNL.0000000000001702.
   PubMed Web of Science ®Google Scholar
• Goetzl EJ, Boxer A, Schwartz JB, Abner EL, Petersen RC, Miller BL, Carlson OD, Mustapic M, Kapogiannis D. Low neural exosomal levels of cellular survival factors in Alzheimer’s disease. Ann Clin Transl Neurol. 2015; 2(7): 769–73. doi: 10.1002/acn3.211.
   PubMed Web of Science ®Google Scholar
• Fiandaca MS, Kapogiannis D, Mapstone M, Boxer A, Eitan E, Schwartz JB, Abner EL, Petersen RC, Federoff HJ, Miller BL, et al. Identification of preclinical Alzheimer’s disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study. Alzheimers Dement. 2015; 11(6): 600–7 e1. doi: 10.1016/j.jalz.2014.06.008.
   PubMed Web of Science ®Google Scholar
• Hamlett ED, Ledreux A, Potter H, Chial HJ, Patterson D, Espinosa JM, Bettcher BM, Granholm AC. Exosomal biomarkers in Down syndrome and Alzheimer’s disease. Free Radic Biol Med. 2018; 114: 110–21. doi: 10.1016/j.freeradbiomed.2017.08.028.
   PubMed Web of Science ®Google Scholar
• Terrio H, Brenner LA, Ivins BJ, Cho JM, Helmick K, Schwab K, Scally K, Bretthauer R, Warden D. Traumatic brain injury screening: preliminary findings in a US Army Brigade Combat Team. J Head Trauma Rehabil. 2009; 24(1): 14–23. doi: 10.1097/HTR.0b013e31819581d8.
   PubMed Web of Science ®Google Scholar
• King PR, Donnelly KT, Donnelly JP, Dunnam M, Warner G, Kittleson CJ, Bradshaw CB, Alt M, Meier ST. Psychometric study of the Neurobehavioral Symptom Inventory. J Rehabil Res Dev. 2012; 49(6): 879–88. doi: 10.1682/JRRD.2011.03.0051.
   PubMed Web of Science ®Google Scholar
• Wilkins KC, Lang AJ, Norman SB. Synthesis of the psychometric properties of the PTSD checklist (PCL) military, civilian, and specific versions. Depress Anxiety. 2011; 28(7): 596–606. doi: 10.1002/da.v28.7.
   PubMed Web of Science ®Google Scholar
• Trivedi MH, Rush AJ, Ibrahim HM, Carmody TJ, Biggs MM, Suppes T, Crismon ML, Shores-Wilson K, Toprac MG, Dennehy EB, et al. The inventory of depressive symptomatology, clinician rating (IDS-C) and self-report (IDS-SR), and the quick inventory of depressive symptomatology, clinician rating (QIDS-C) and self-report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med. 2004; 34(1): 73–82.
   PubMed Web of Science ®Google Scholar
• Witwer KW, Buzas EI, Bemis LT, Bora A, Lasser C, Lotvall J, Nolte-’T Hoen EN, Piper MG, Sivaraman S. Skog J, et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles. 2013; 2: 34–39.
   PubMedGoogle Scholar
• Jin Y, Chen K, Wang Z, Wang Y, Liu J, Lin L, Shao Y, Gao L, Yin H, Cui C, et al. DNA in serum extracellular vesicles is stable under different storage conditions. BMC Cancer. 2016; 16(1): 753. doi: 10.1186/s12885-016-2783-2.
   PubMed Web of Science ®Google Scholar
• Sokolova V, Ludwig AK, Hornung S, Rotan O, Horn PA, Epple M, Giebel B. Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf B: Biointerfaces. 2011; 87(1): 146–50. doi: 10.1016/j.colsurfb.2011.05.013.
   PubMed Web of Science ®Google Scholar
• Saenz-Cuesta M, Arbelaiz A, Oregi A, Irizar H, Osorio-Querejeta I, Munoz-Culla M, Banales JM, Falcon-Perez JM, Olascoaga J, Otaegui D. Methods for extracellular vesicles isolation in a hospital setting. Front Immunol. 2015; 6: 50. doi: 10.3389/fimmu.2015.00050.
   PubMed Web of Science ®Google Scholar
• Rissin DM, Fournier DR, Piech T, Kan CW, Campbell TG, Song L, Chang L, Rivnak AJ, Patel PP, Provuncher GK, et al. Simultaneous detection of single molecules and singulated ensembles of molecules enables immunoassays with broad dynamic range. Anal Chem. 2011; 83(6): 2279–85. doi: 10.1021/ac103161b.
   PubMed Web of Science ®Google Scholar
• Magnoni S, Esparza TJ, Conte V, Carbonara M, Carrabba G, Holtzman DM, Zipfel GJ, Stocchetti N, Brody DL. Tau elevations in the brain extracellular space correlate with reduced amyloid-beta levels and predict adverse clinical outcomes after severe traumatic brain injury. Brain. 2012; 135(Pt 4): 1268–80. doi: 10.1093/brain/awr286.
   PubMed Web of Science ®Google Scholar
• McKee AC, Stein TD, Kiernan PT, Alvarez VE. The neuropathology of chronic traumatic encephalopathy. Brain Pathol. 2015; 25(3): 350–64. doi: 10.1111/bpa.12248.
   PubMed Web of Science ®Google Scholar
• Ryu J, Horkayne-Szakaly I, Xu L, Pletnikova O, Leri F, Eberhart C, Troncoso JC, Koliatsos VE. The problem of axonal injury in the brains of veterans with histories of blast exposure. Acta Neuropathol Commun. 2014; 2: 153. doi: 10.1186/s40478-014-0153-3.
   PubMed Web of Science ®Google Scholar
• Armstrong RA, McKee AC, Stein TD, Alvarez VE, Cairns NJ. A quantitative study of tau pathology in eleven cases of chronic traumatic encephalopathy. Neuropathol Appl Neurobiol. 2016; 2: 185–192.
   PubMed Web of Science ®Google Scholar
• Scott G, Ramlackhansingh AF, Edison P, Hellyer P, Cole J, Veronese M, Leech R, Greenwood RJ, Turkheimer FE, Gentleman SM, et al. Amyloid pathology and axonal injury after brain trauma. Neurology. 2016; 86(9): 821–28. doi: 10.1212/WNL.0000000000002413.
   PubMed Web of Science ®Google Scholar
• Rajendran L, Knobloch M, Geiger KD, Dienel S, Nitsch R, Simons K, Konietzko U. Increased Abeta production leads to intracellular accumulation of Abeta in flotillin-1-positive endosomes. Neurodegener Dis. 2007; 4(2–3): 164–70. doi: 10.1159/000101841.
   PubMed Web of Science ®Google Scholar
• Perez-Gonzalez R, Gauthier SA, Kumar A, Levy E. The exosome secretory pathway transports amyloid precursor protein carboxyl-terminal fragments from the cell into the brain extracellular space. J Biol Chem. 2012; 287(51): 43108–15. doi: 10.1074/jbc.M112.404467.
   PubMed Web of Science ®Google Scholar
• Dinkins MB, Dasgupta S, Wang G, Zhu G, Bieberich E. Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer’s disease. Neurobiol Aging. 2014; 35(8): 1792–800. doi: 10.1016/j.neurobiolaging.2014.02.012.
   PubMed Web of Science ®Google Scholar
• Falker C, Hartmann A, Guett I, Dohler F, Altmeppen H, Betzel C, Schubert R, Thurm D, Wegwitz F, Joshi P, et al. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity. J Neurochem. 2016; 137(1): 88–100. doi: 10.1111/jnc.13514.
   PubMed Web of Science ®Google Scholar
• Yuyama K, Sun H, Mitsutake S, Igarashi Y. Sphingolipid-modulated exosome secretion promotes clearance of amyloid-beta by microglia. J Biol Chem. 2012; 287(14): 10977–89. doi: 10.1074/jbc.M111.324616.
   PubMed Web of Science ®Google Scholar
• Saman S, Lee NC, Inoyo I, Jin J, Li Z, Doyle T, McKee AC, Hall GF. Proteins recruited to exosomes by tau overexpression implicate novel cellular mechanisms linking tau secretion with Alzheimer’s disease. J Alzheimers Dis. 2014; 40(Suppl 1): S47–70.
   PubMed Web of Science ®Google Scholar
• Baker S, Polanco JC, Gotz J. Extracellular vesicles containing P301L mutant tau accelerate pathological tau phosphorylation and oligomer formation but do not seed mature neurofibrillary tangles in ALZ17 mice. J Alzheimers Dis. 2016; doi: 10.3233/JAD-160371.
   Web of Science ®Google Scholar
• Kirchhoff C, Buhmann S, Bogner V, Stegmaier J, Leidel B, Braunstein V, Mutschler W, Cerebrospinal BP. IL-10 concentration is elevated in non-survivors as compared to survivors after severe traumatic brain injury. Eur J Med Res. 2008; 13(10): 464–68.
   PubMed Web of Science ®Google Scholar
• Gola H, Engler H, Sommershof A, Adenauer H, Kolassa S, Schedlowski M, Groettrup M, Elbert T, Kolassa I-T. Posttraumatic stress disorder is associated with an enhanced spontaneous production of pro-inflammatory cytokines by peripheral blood mononuclear cells. BMC Psychiatry. 2013; 13(1): 40. doi: 10.1186/1471-244X-13-40.
   PubMed Web of Science ®Google Scholar
• Nie H, Peng Z, Lao N, Wang H, Chen Y, Fang Z, Hou W, Gao F, Li X, Xiong L, et al. Rosmarinic acid ameliorates PTSD-like symptoms in a rat model and promotes cell proliferation in the hippocampus. Prog Neuro-Psychopharmacol Biol Psychiatry. 2014; 51: 16–22. doi: 10.1016/j.pnpbp.2014.01.002.
   PubMed Web of Science ®Google Scholar
• Ebenezer PJ, Wilson CB, Wilson LD, Nair AR, Francis J. The anti-inflammatory effects of blueberries in an animal model of post-traumatic stress disorder (PTSD). PLoS One. 2016; 11(9): e0160923. doi: 10.1371/journal.pone.0160923.
   PubMed Web of Science ®Google Scholar
• Lai CP, Breakefield XO. Role of exosomes/microvesicles in the nervous system and use in emerging therapies. Front Physiol. 2012; 3: 228. doi: 10.3389/fphys.2012.00228.
   PubMed Web of Science ®Google Scholar